中国生物技术股份有限公司 specializes in the research and development of vaccines and new drugs, contributing to public health.

中国生物技术股份有限公司

China National Biotec Group Company Limited | 801 followers on LinkedIn. China National Biotec Group (CNBG), is a subsidiary of China National Pharmaceutical Group corporation (SINOPHARM), and has 6 subordinate biological products research institutes in Beijing, Changchun, Chengdu, Lanzhou, Shanghai and Wuhan as well as Beijing Tiantan Biological Products Co., Ltd. 

CNBG is a professional institute which has the longest history in vaccine and blood production research and development in China, and is the biggest biotech corporation combines research, development, production and supply in one. To date, the total assets of the group is 15.6 billion RMB, main operating revenue exceeds 5 billion RMB, is the fourth biggest vaccine manufacturer in the world.

Sr. Manager - BD, Licensing & Investment - Intl. Cooperation Dept - China National Biotec Group

Hai (Harrison) L.

Catalyzing the future of anti-cancer biologics with AI. (WeChat 18501996335)

Chi Zhang

International BD at Sinopharm CNBG

Tianfang(Chloé) XU

Senior Project Director, China National Biotec Group

Naiyin Wang

China National Biotec Group Company Limited

COM

CN:COM:CNBG

中国生物技术股份有限公司